glp-1 for psoriatic arthritis The list of conditions which drugs provide benefit independent of weight loss keeps growing. Add #AAD26 @AADskin Study: GLP-1 Drug Plus Biologic

This analysis estimates the number of Medicare Part D enrollees who could potentially qualify for the Bridge program by meeting all of the eligibility criteria, based on claims data from 2023.

PlexusDx provides personalized guidance for combining these medications

Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings

Louisianas Medicaid program could expand access to popular weight-loss medications such as Wegovy and Zepbound for obesity treatment starting in January.